This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
1 K Yazawa , K Imai & Z Tamura (1978) Oligosaccharides and polysaccharides specifically utilizable by bifidobacteria. Chem Pharm Bull (Tokyo) 26, 3306–3311.
2 T Mitsuoka , H Hidaka & T Eida (1987) Effect of fructo-oligosaccharides on intestinal microflora. Nahrung 31, 427–436.
7 HJ Harmsen , AC Wildeboer-Veloo , J Grijpstra , (2000) Development of 16S rRNA-based probes for the Coriobacterium group and the Atopobium cluster and their application for enumeration of Coriobacteriaceae in human feces from volunteers of different age groups. Appl Environ Microbiol 66, 4523–4527.
8 HJ Harmsen , GC Raangs , T He , (2002) Extensive set of 16S rRNA-based probes for detection of bacteria in human feces. Appl Environ Microbiol 68, 2982–2990.
11 EG Zoetendal , A von Wright , T Vilpponen-Salmela , (2002) Mucosa-associated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces. Appl Environ Microbiol 68, 3401–3407.
12 X Wang , SP Heazlewood , DO Krause , (2003) Molecular characterization of the microbial species that colonize human ileal and colonic mucosa by using 16S rDNA sequence analysis. J Appl Microbiol 95, 508–520.
13 M Wang , S Ahrne , B Jeppsson , (2005) Comparison of bacterial diversity along the human intestinal tract by direct cloning and sequencing of 16S rRNA genes. FEMS Microbiol Ecol 54, 219–231.
14 PB Eckburg , EM Bik , CN Bernstein , (2005) Diversity of the human intestinal microbial flora. Science 308, 1635–1638.
15 H Hayashi , R Takahashi , T Nishi , (2005) Molecular analysis of jejunal, ileal, caecal and recto-sigmoidal human colonic microbiota using 16S rRNA gene libraries and terminal restriction fragment length polymorphism. J Med Microbiol 54, 1093–1101.
16 GL Green , J Brostoff , B Hudspith , (2006) Molecular characterization of the bacteria adherent to human colorectal mucosa. J Appl Microbiol 100, 460–469.
20 GR Gibson & M Roberfroid (2008) Handbook of Prebiotics. Boca Raton, FL: CRC Press.
21 JH Cummings , JM Antoine , F Azpiroz , (2004) PASSCLAIM – gut health and immunity. Eur J Nutr 43, Suppl. 2, II118–II173.
27 GA O'May , N Reynolds & GT Macfarlane (2005) Effect of pH on an in vitro model of gastric microbiota in enteral nutrition patients. Appl Environ Microbiol 71, 4777–4783.
28 GT Macfarlane , S Macfarlane & GR Gibson (1998) Validation of a three-stage compound continuous culture system for investigating the effect of retention time on the ecology and metabolism of bacteria in the human colon. Microb Ecol 35, 180–187.
29 SH Duncan , RI Aminov , KP Scott , (2006) Proposal of Roseburia faecis sp. nov., Roseburia hominis sp. nov. and Roseburia inulinivorans sp. nov., based on isolates from human faeces. Int J Syst Evol Microbiol 56, 2437–2441.
30 M Derrien , EE Vaughan , CM Plugge , (2004) Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. Int J Syst Evol Microbiol 54, 1469–1476.
31 AW Walker , SH Duncan , EC William Leitch , (2005) pH and peptide supply can radically alter bacterial populations and short-chain fatty acid ratios within microbial communities from the human colon. Appl Environ Microbiol 71, 3692–3700.
33 C Manichanh , L Rigottier-Gois , E Bonnaud , (2006) Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut 55, 205–211.
34 JA Stewart , VS Chadwick & A Murray (2005) Investigations into the influence of host genetics on the predominant eubacteria in the faecal microflora of children. J Med Microbiol 54, 1239–1242.
36 HJ Flint , EA Bayer , MT Rincon , (2008) Polysaccharide utilization by gut bacteria: potential for new insights from genomic analysis. Nat Rev Microbiol 6, 121–131.
37 JH Cummings & GT Macfarlane (1991) The control and consequences of bacterial fermentation in the human colon. J Appl Bacteriol 70, 443–459.
38 IR Rowland , AK Mallett & A Wise (1985) The effect of diet on the mammalian gut flora and its metabolic activities. Crit Rev Toxicol 16, 31–103.
41 GT Macfarlane , GR Gibson & JH Cummings (1992) Comparison of fermentation reactions in different regions of the human colon. J Appl Bacteriol 72, 57–64.
42 SA Bingham , S Pett & KC Day (1990) NSP intake of a representative sample of British adults. J Hum Nutr Diet 3, 339–344.
44 HN Englyst & GT Macfarlane (1986) Breakdown of resistant and readily digestible starch by human gut bacteria. J Sci Food Agric 37, 699–706.
49 JH Cummings (1981) Short chain fatty acids in the human colon. Gut 22, 763–779.
54 NB Dass , AK John , AK Bassil , (2007) The relationship between the effects of short-chain fatty acids on intestinal motility in vitro and GPR43 receptor activation. Neurogastroenterol Motil 19, 66–74.
60 W Scheppach (1996) Treatment of distal ulcerative colitis with short-chain fatty acid enemas. A placebo-controlled trial. German-Austrian SCFA Study Group. Dig Dis Sci 41, 2254–2259.
61 Z Tamura (1983) Nutriology of bifidobacteria. Bifidobact Microfl 2, 3–16.
62 SA Hughes , PR Shewry , L Li , (2007) In vitro fermentation by human fecal microflora of wheat arabinoxylans. J Agric Food Chem 55, 4589–4595.
63 X Wang & GR Gibson (1993) Effects of the in vitro fermentation of oligofructose and inulin by bacteria growing in the human large intestine. J Appl Bacteriol 75, 373–380.
64 CE Rycroft , MR Jones , GR Gibson , (2001) A comparative in vitro evaluation of the fermentation properties of prebiotic oligosaccharides. J Appl Microbiol 91, 878–887.
65 K Hayakawa , J Mizutani , K Wada , (1990) Effects of soybean oligosaccharides on human faecal flora. Microbial Ecol Health Dis 3, 293–303.
66 A Sghir , JM Chow & RI Mackie (1998) Continuous culture selection of bifidobacteria and lactobacilli from human faecal samples using fructooligosaccharide as selective substrate. J Appl Microbiol 85, 769–777.
67 GR Gibson & X Wang (1994) Enrichment of bifidobacteria from human gut contents by oligofructose using continuous culture. FEMS Microbiol Lett 118, 121–127.
68 GR Gibson & X Wang (1994) Regulatory effects of bifidobacteria on the growth of other colonic bacteria. J Appl Bacteriol 77, 412–420.
70 AJ McBain & GT Macfarlane (2001) Modulation of genotoxic enzyme activities by non-digestible oligosaccharide metabolism in in-vitro human gut bacterial ecosystems. J Med Microbiol 50, 833–842.
72 RJ Palframan , GR Gibson & RA Rastall (2002) Effect of pH and dose on the growth of gut bacteria on prebiotic carbohydrates in vitro. Anaerobe 8, 287–292.
74 T van de Wiele , N Boon , S Possemiers , (2004) Prebiotic effects of chicory inulin in the simulator of the human intestinal microbial ecosystem. FEMS Microbiol Ecol 51, 143–153.
75 T van de Wiele , N Boon , S Possemiers , (2007) Inulin-type fructans of longer degree of polymerization exert more pronounced in vitro prebiotic effects. J Appl Microbiol 102, 452–460.
76 M Minekus , M Smeets-Peeters , A Bernalier , (1999) A computer-controlled system to simulate conditions of the large intestine with peristaltic mixing, water absorption and absorption of fermentation products. Appl Microbiol Biotechnol 53, 108–114.
77 K Venema , MHMC van Nuenen , EG van den Heuvel , (2003) The effect of lactulose on the composition of the intestinal microbiota and short-chain fatty acid production in human volunteers and a computercontrolled model of the proximal large intestine. Microb Ecol Health Dis 15, 94–105.
81 RD Wagner (2008) Effects of microbiota on GI health: gnotobiotic research. Gi Microb Regul Immune Sys 635, 41–56.
82 D Kelly , T King & R Aminov (2007) Importance of microbial colonization of the gut in early life to the development of immunity. Mutat Res 622, 58–69.
83 JL Round & SK Mazmanian (2009) The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 9, 313–323.
84 V Gaboriau-Routhiau , S Rakotobe , E Lecuyer , (2009) The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity 31, 677–689.
85 M Rescigno , M Urbano , B Valzasina , (2001) Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat Immunol 2, 361–367.
87 D Artis (2008) Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut. Nat Rev Immunol 8, 411–420.
88 R Medzhitov (2007) Recognition of microorganisms and activation of the immune response. Nature 449, 819–826.
89 RE Vance , RR Isberg & DA Portnoy (2009) Patterns of pathogenesis: discrimination of pathogenic and nonpathogenic microbes by the innate immune system. Cell Host Microbe 6, 10–21.
90 S Rakoff-Nahoum , J Paglino , F Eslami-Varzaneh , (2004) Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118, 229–241.
91 NE Nilsson , K Kotarsky , C Owman , (2003) Identification of a free fatty acid receptor, FFA2R, expressed on leukocytes and activated by short-chain fatty acids. Biochem Biophys Res Commun 303, 1047–1052.
92 E Le Poul , C Loison , S Struyf , (2003) Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation. J Biol Chem 278, 25481–25489.
93 S Karaki , H Tazoe , H Hayashi , (2008) Expression of the short-chain fatty acid receptor, GPR43, in the human colon. J Mol Histol 39, 135–142.
94 H Tazoe , Y Otomo , S Karaki , (2009) Expression of short-chain fatty acid receptor GPR41 in the human colon. Biomed Res 30, 149–156.
95 CR Cavaglieri , A Nishiyama , LC Fernandes , (2003) Differential effects of short-chain fatty acids on proliferation and production of pro- and anti-inflammatory cytokines by cultured lymphocytes. Life Sci 73, 1683–1690.
96 KM Maslowski , AT Vieira , A Ng , (2009) Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 461, 1282–1286.
101 S Seifert & B Watzl (2008) Prebiotics and the immune system: review of experimental and human data. In Handbook of Prebiotics, pp. 143–162 [ GR Gibson and M Roberfroid , editors]. Boca Raton, FL: CRC Press.
102 D Bunout , S Hirsch , DLM Pia , (2002) Effects of prebiotics on the immune response to vaccination in the elderly. JPEN J Parenter Enteral Nutr 26, 372–376.
103 D Bunout , G Barrera , S Hirsch , (2004) Effects of a nutritional supplement on the immune response and cytokine production in free-living Chilean elderly. JPEN J Parenter Enteral Nutr 28, 348–354.
105 E van Hoffen , B Ruiter , J Faber , (2009) A specific mixture of short-chain galacto-oligosaccharides and long-chain fructo-oligosaccharides induces a beneficial immunoglobulin profile in infants at high risk for allergy. Allergy 64, 484–487.
106 AM Bakker-Zierikzee , EA Tol , H Kroes , (2006) Faecal SIgA secretion in infants fed on pre- or probiotic infant formula. Pediatr Allergy Immunol 17, 134–140.
108 Y Guigoz , F Rochat , G Perruisseau-Carrier , (2002) Effects of oligosaccharide on the faecal flora and non-specific immune system in elderly people. Nutr Res 22, 13–25.
111 J Lindsay , K Whelan , A Stagg , (2006) Clinical, microbiological, and immunological effects of fructo-oligosaccharide in patients with Crohn's disease. Gut 55, 348–355.
112 F Hoentjen , GW Welling , HJ Harmsen , (2005) Reduction of colitis by prebiotics in HLA-B27 transgenic rats is associated with microflora changes and immunomodulation. Inflamm Bowel Dis 11, 977–985.
113 G Moro , S Arslanoglu , B Stahl , (2006) A mixture of prebiotic oligosaccharides reduces the incidence of atopic dermatitis during the first six months of age. Arch Dis Child 91, 814–819.
114 T Fukasawa , K Murashima , I Matsumoto , (2007) Identification of marker genes for intestinal immunomodulating effect of a fructooligosaccharide by DNA microarray analysis. J Agric Food Chem 55, 3174–3179.
118 C Agostoni , I Axelsson , O Goulet , (2004) Prebiotic oligosaccharides in dietetic products for infants: a commentary by the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr 39, 465–473.
120 WKW Yap , S Mohamed , JM Husni , (2008) Changes in infants faecal characteristics and microbiota by inulin supplementation. J Clin Nutr Biochem 43, 159–166.
122 XM Ben , J Li , ZT Feng , (2008) Low level of galacto-oligosaccharide in infant formula stimulates growth of intestinal Bifidobacteria and Lactobacilli. World J Gastroenterol 14, 6564–6568.
123 S Fanaro , B Marten , R Bagna , (2009) Galacto-oligosaccharides are bifidogenic and safe at weaning: a double-blind randomized multicenter study. J Pediatr Gastroenterol Nutr 48, 82–88.
124 F Magne , W Hachelaf , A Suau , (2008) Effects on faecal microbiota of dietary and acidic oligosaccharides in children during partial formula feeding. J Pediatr Gastroenterol Nutr 46, 580–588.
127 PA Scholtens , MS Alles , JG Bindels , (2006) Bifidogenic effects of solid weaning foods with added prebiotic oligosaccharides: a randomised controlled clinical trial. J Pediatr Gastroenterol Nutr 42, 553–559.
129 E Bruzzese , M Volpicelli , V Squeglia , (2009) A formula containing galacto- and fructo-oligosaccharides prevents intestinal and extra-intestinal infections: an observational study. Clin Nutr 28, 156–161.
131 JH Hoekstra , H Szajewska , MA Zikri , (2004) Oral rehydration solution containing a mixture of non-digestible carbohydrates in the treatment of acute diarrhea: a multicenter randomized placebo controlled study on behalf of the ESPGHAN working group on intestinal infections. J Pediatr Gastroenterol Nutr 39, 239–245.
132 CM Surawicz (2003) Probiotics, antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in humans. Best Pract Res Clin Gastroenterol 17, 775–783.
133 AL D'Souza , C Rajkumar , J Cooke , (2002) Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis. BMJ 324, 1361.
134 F Cremonini , CS Di , EC Nista , (2002) Meta-analysis: the effect of probiotic administration on antibiotic-associated diarrhoea. Aliment Pharmacol Ther 16, 1461–1467.
135 H Szajewska & J Mrukowicz (2005) Meta-analysis: non-pathogenic yeast Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea. Aliment Pharmacol Ther 22, 365–372.
136 JA Hawrelak , DL Whitten & SP Myers (2005) Is Lactobacillus rhamnosus GG effective in preventing the onset of antibiotic-associated diarrhoea: a systematic review. Digestion 72, 51–56.
137 H Szajewska , M Ruszczynski & A Radzikowski (2006) Probiotics in the prevention of antibiotic-associated diarrhea in children: a meta-analysis of randomized controlled trials. J Pediatr 149, 367–372.
138 O Brunser , M Gotteland , S Cruchet , (2006) Effect of a milk formula with prebiotics on the intestinal microbiota of infants after an antibiotic treatment. Pediatr Res 59, 451–456.
139 M Kalliomaki , P Kirjavainen , E Eerola , (2001) Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J Allergy Clin Immunol 107, 129–134.
142 JH Cummings , S Christie & TJ Cole (2001) A study of fructo oligosaccharides in the prevention of travellers' diarrhoea. Aliment Pharmacol Ther 15, 1139–1145.
143 S Lewis , S Burmeister , S Cohen , (2005) Failure of dietary oligofructose to prevent antibiotic-associated diarrhoea. Aliment Pharmacol Ther 21, 469–477.
144 S Lewis , S Burmeister & J Brazier (2005) Effect of the prebiotic oligofructose on relapse of Clostridium difficile-associated diarrhea: a randomized, controlled study. Clin Gastroenterol Hepatol 3, 442–448.
145 R Spiller , Q Aziz , F Creed , (2007) Guidelines on the irritable bowel syndrome: mechanism and practical management. Gut 56, 1770–1798.
146 GF Longstreth , WG Thompson , WD Chey , (2006) Functional bowel disorders. Gastroenterology 130, 1480–1491.
147 J Serra , B Salvioli , F Azpiroz , (2002) Lipid-induced intestinal gas retention in irritable bowel syndrome. Gastroenterology 123, 700–706.
148 R Spiller (2008) Review Article: probiotics and prebiotics in irritable bowel syndrome. Aliment Pharmacol Ther 28, 385–396.
150 JM Si , YC Yu , YF Fan , (2004) Intestinal microecology and quality of life in irritable bowel syndrome patients. World J Gastroenterol 10, 1802–1805.
151 EM Malinen , T Rinttilä , K Kajander , (2005) Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am J Gastroenterol 100, 373–382.
153 A Kassinen , L Krogius , H Mäkivuokko , (2007) The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology 133, 24–33.
154 APM Kerckhoffs , M Samsom , ME van der Rest , (2009) Lower bifidobacteria counts in both duodenal mucose-associated and faecal microbiota in irritable bowel syndrome patients. World J Gastroenterol 15, 2887–2892.
155 J Maukonen , R Satokari , J Mattö , (2006) Prevalence and temporal stability of selected clostridal groups in irritable bowel syndrome in relation to predominant faecal bacteria. J Med Microbiol 55, 625–633.
156 M Nyman (2002) Fermentation and bulking capacity of indigestible carbohydrates: the case of inulin and oligofructose. Br J Nutr 87, S163–S168.
157 V de Preter , T Vanhoutte , G Huys , (2008) Baseline microbiota activity and initial bifidobacteria counts influence responses to prebiotic dosing in healthy subjects. Aliment Pharmacol Ther 27, 504–513.
158 E Furrie , S Macfarlane , A Kennedy , (2005) Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial. Gut 54, 1346.
159 F Casellas , N Borruel , A Torrejon , (2007) Oral oligofructose-enriched inulin supplementation in acute ulcerative colitis is well tolerated and associated with lowered faecal calprotectin. Aliment Pharmacol Ther 25, 1061–1067.
160 KF Cook , L Rabeneck , CJ Campbell , (1999) Evaluation of a multidimensional measure of dyspepsia-related health for use in a randomized clinical trial. J Clin Epidemiol 52, 381–392.
166 DBA Silk , A Davis , J Vulevic , (2009) Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome. Aliment Pharmacol Ther 29, 508–518.
167 EV Loftus Jr (2004) Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 126, 1504–1517.
168 SP Travis , EF Stange , M Lemann , (2006) European Crohn's and Colitis Organisation. European evidence based consensus on the diagnosis and management of Crohn's disease: current management. Gut 55, 16–35.
169 AJ Lucendo & LC De Rezende (2009) Importance of nutrition in inflammatory bowel disease. World J Gastroenterol 15, 2081–2088.
171 M Schwartz & R Cohen (2008) Optimizing conventional therapy for inflammatory bowel disease. Curr Gastroenterol Rep 10, 585–590.
172 MJ Carter , AJ Lobo & SP Travis (2004) Guidelines for the management of inflammatory bowel disease in adults. Gut 53, Suppl. 5, V1–V16.
174 K Teahon , M Pearson , AJ Levi , (1995) Practical aspects of enteral nutrition in the management of Crohn's disease. J Parenter Enteral Nutr 19, 365–368.
175 MG Neuman (2007) Immune dysfunction in inflammatory bowel disease. Transl Res 149, 173–186.
176 JO Lindsay & HJ Hodgson (2001) The immunoregulatory cytokine interleukin-10 – a therapy for Crohn's disease? Aliment Pharmacol Ther 15, 16.
177 SJ Brown & L Mayer (2007) The immune response in inflammatory bowel disease. Am J Gastroenterol 102, 2058–2069.
179 R Fasoli , MG Kettlewell , N Mortensen , (1990) Response to faecal challenge in defunctioned colonic Crohn's disease: prediction of long-term course. Br J Surg 77, 616–617.
180 M Chichlowski & LP Hale (2008) Bacterial-mucosal interactions in inflammatory bowel disease: an alliance gone bad. Am J Physiol Gastrointest Liver Physiol 295, G1139–G1149.
181 JP Hugot , M Chamaillard , H Zouali , (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411, 599–603.
182 H Zhang , D Massey , M Tremelling , (2008) Genetics of inflammatory bowel disease: clues to pathogenesis. Br Med Bull 87, 17–30.
183 E Miyauchi , H Morita & S Tanabe (2009) Lactobacillus rhamnosus alleviates intestinal barrier dysfunction in part by increasing expression of zonula occludens-1 and myosin light-chain kinase in vivo. J Dairy Sci 92, 2400–2408.
184 VE Garcia , M De Lourdes De Abreu Ferrari , TH Oswaldo Da Gama , (2008) Influence of Saccharomyces boulardii on the intestinal permeability of patients with Crohn's disease in remission. Scand J Gastroenterol 43, 842–848.
185 AL Hart , K Lammers , P Brigidi , (2004) Modulation of human dendritic cell phenotype and function by probiotic bacteria. Gut 53, 1602–1609.
187 RB Sartor (2008) Microbial influences in inflammatory bowel diseases. Gastroenterology 134, 577–594.
189 P Seksik , L Rigottier-Gois , G Gramet , (2003) Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon. Gut 52, 237–242.
190 H Sokol , P Seksik , JP Furet , (2009) Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis 15, 1183–1189.
191 S Macfarlane , E Furrie , JH Cummings , (2004) Chemotaxonomic analysis of bacterial populations colonizing the rectal mucosa in patients with ulcerative colitis. Clin Infect Dis 38, 1690–1699.
192 M Mylonaki , NB Rayment , DS Rampton , (2005) Molecular characterization of rectal mucosa-associated bacterial flora in inflammatory bowel disease. Inflamm Bowel Dis 11, 481–487.
193 A Swidsinski , A Ladhoff , A Pernthaler , (2002) Mucosal flora in inflammatory bowel disease. Gastroenterology 122, 44–54.
194 DN Frank , AL St Amand , RA Feldman , (2007) Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A 104, 13780–13785.
195 H Sokol , P Lepage , P Seksik , (2006) Temperature gradient gel electrophoresis of fecal 16S rRNA reveals active Escherichia coli in the microbiota of patients with ulcerative colitis. J Clin Microbiol 44, 3172–3177.
196 M Martinez-Medina , X Aldeguer , F Gonzalez-Huix , (2006) Abnormal microbiota composition in the ileocolonic mucosa of Crohn's disease patients as revealed by polymerase chain reaction-denaturing gradient gel electrophoresis. Inflamm Bowel Dis 12, 1136–1145.
197 H Sokol , B Pigneur , L Watterlot , (2008) Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A 105, 16731–16736.
199 SJ Langlands , MJ Hopkins , N Coleman , (2004) Prebiotic carbohydrates modify the mucosa associated microflora of the human large bowel. Gut 53, 1610–1616.
201 PN Burger-van , A Vincent , PJ Puiman , (2009) The regulation of intestinal mucin MUC2 expression by short-chain fatty acids: implications for epithelial protection. Biochem J 420, 211–219.
202 RD Pullan , GA Thomas , M Rhodes , (1994) Thickness of adherent mucus gel on colonic mucosa in humans and its relevance to colitis. Gut 35, 353–359.
205 G Friedman & J George (2000) Treatment of refractory ‘pouchitis’ with prebiotic and probiotic therapy. Gastroenterology 118, A778.
206 CF Welters , E Heineman , FB Thunnissen , (2002) Effect of dietary inulin supplementation on inflammation of pouch mucosa in patients with an ileal pouch-anal anastomosis. Dis Colon Rectum 45, 621–627.
209 S Fujimori , K Gudis , K Mitsui , (2009) A randomized controlled trial on the efficacy of synbiotic versus probiotic or prebiotic treatment to improve the quality of life in patients with ulcerative colitis. Nutrition 25, 520–525.
211 JL Benjamin , CRH Hedin , A Koutsoumpas , (2010) No clinical benefit of prebiotics in the treatment of active Crohn's disease: a double-blind, randomised, placebo-controlled trial. Gut, 59: .
212 I Chermesh , A Tamir , R Reshef , (2007) Failure of Synbiotic 2000 to prevent postoperative recurrence of Crohn's disease. Dig Dis Sci 52, 385–389.
213 C Su , JD Lewis , B Goldberg , (2007) A meta-analysis of the placebo rates of remission and response in clinical trials of active ulcerative colitis. Gastroenterology 132, 516–526.
214 C Su , GR Lichtenstein , K Krok , (2004) A meta-analysis of the placebo rates of remission and response in clinical trials of active Crohn's disease. Gastroenterology 126, 1257–1269.
216 I Rowland (2009) The role of the gastrointestinal microflora in colorectal cancer. Curr Pharmaceut Design 15, 1524–1527.
219 Y Saito , T Takano & I Rowland (1992) Effects of soybean oligosaccharides on the human gut microflora in in vitro culture. Microb Ecol Health Dis 5, 105–110.
221 IR Rowland , CJ Rumney , JT Coutts , (1998) Effect of Bifidobacterium longum and inulin on gut bacterial metabolism and carcinogen-induced aberrant crypt foci in rats. Carcinogenesis 19, 281–285.
222 H Hidaka , T Eida , T Takizawa , (1986) Effects of fructooligosaccharides on intestinal flora and human health. Bifidobact Microfl 5, 37–50.
223 IR Rowland & R Tanaka (1993) The effects of transgalactosylated oligosaccharides on gut flora metabolism in rats associated with a human faecal microflora. J Appl Bacteriol 74, 667–674.
224 R Tanaka , H Takayama , M Morotomi , (1983) Effects of administration of TOS and Bifidobacterium breve 4006 on the human fecal flora. Bifidobact Microfl 2, 17–24.
226 TP Pretlow , MA O'Riordan , GA Somich , (1992) Aberrant crypts correlate with tumor incidence in F344 rats treated with azoxymethane and phytate. Carcinogenesis 13, 1509–1512.
227 CV Rao , D Chou , B Simi , (1998) Prevention of colonic aberrant crypt foci and modulation of large bowel microbial activity by dietary coffee fiber, inulin and pectin. Carcinogenesis 19, 1815–1819.
230 BS Reddy , R Hamid & CV Rao (1997) Effect of dietary oligofructose and inulin on colonic preneoplastic aberrant crypt foci inhibition. Carcinogenesis 18, 1371–1374.
232 M Poulsen , AM Molck & BL Jacobsen (2002) Different effects of short- and long-chained fructans on large intestinal physiology and carcinogen-induced aberrant crypt foci in rats. Nutr Cancer 42, 194–205.
233 H Jacobsen , M Poulsen , LO Dragsted , (2006) Carbohydrate digestibility predicts colon carcinogenesis in azoxymethane-treated rats. Nutr Cancer 55, 163–170.
235 A Challa , DR Rao , CB Chawan , (1997) Bifidobacterium longum and lactulose suppress azoxymethane-induced colonic aberrant crypt foci in rats. Carcinogenesis 18, 517–521.
237 MV Wijnands , HC Schoterman , JB Bruijntjes , (2001) Effect of dietary galacto-oligosaccharides on azoxymethane-induced aberrant crypt foci and colorectal cancer in Fischer 344 rats. Carcinogenesis 22, 127–132.
238 S Nakanishi , K Kataoka , T Kuwahara , (2003) Effects of high amylose maize starch and Clostridium butyricum on metabolism in colonic microbiota and formation of azoxymethane-induced aberrant crypt foci in the rat colon. Microbiol Immunol 47, 951–958.
239 MV Wijnands , MJ Appel , VM Hollanders , (1999) A comparison of the effects of dietary cellulose and fermentable galacto-oligosaccharide, in a rat model of colorectal carcinogenesis: fermentable fibre confers greater protection than non-fermentable fibre in both high and low fat backgrounds. Carcinogenesis 20, 651–656.
240 AP Femia , C Luceri , P Dolara , (2002) Antitumorigenic activity of the prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis on azoxymethane-induced colon carcinogenesis in rats. Carcinogenesis 23, 1953–1960.
242 M Mutanen , AM Pajari & SI Oikarinen (2000) Beef induces and rye bran prevents the formation of intestinal polyps in Apc(Min) mice: relation to beta-catenin and PKC isozymes. Carcinogenesis 21, 1167–1173.
243 AM Pajari , J Rajakangas , E Paivarinta , (2003) Promotion of intestinal tumor formation by inulin is associated with an accumulation of cytosolic beta-catenin in Min mice. Int J Cancer 106, 653–660.
249 IR Rowland , CA Bearne , R Fischer , (1996) The effect of lactulose on DNA damage induced by DMH in the colon of human flora-associated rats. Nutr Cancer 26, 37–47.
250 A Klinder , A Forster , G Caderni , (2004) Fecal water genotoxicity is predictive of tumor-preventive activities by inulin-like oligofructoses, probiotics (Lactobacillus rhamnosus and Bifidobacterium lactis), and their synbiotic combination. Nutr Cancer 49, 144–155.
251 P Perrin , F Pierre , Y Patry , (2001) Only fibres promoting a stable butyrate producing colonic ecosystem decrease the rate of aberrant crypt foci in rats. Gut 48, 53–61.
252 R Hughes & IR Rowland (2001) Stimulation of apoptosis by two prebiotic chicory fructans in the rat colon. Carcinogenesis 22, 43–47.
253 DM Commane , CT Shortt , S Silvi , (2005) Effects of fermentation products of pro- and prebiotics on trans-epithelial electrical resistance in an in vitro model of the colon. Nutr Cancer 51, 102–109.
254 M Roberfroid (1993) Dietary fibers, inulin, and oligofructose: a review comparing their physiological effects. Crit Rev Food Sci Nutr 33, 103–148.
258 HW Lopez , C Coudray , MA Levrat-Verny , (2000) Fructooligosaccharides enhance mineral apparent absorption and counteract the deleterious effects of phytic acid on mineral homeostasis in rats. J Nutr Biochem 11, 500–508.
259 T Lutz & E Scharrer (1991) Effect of short-chain fatty acids on calcium absorption by the rat colon. Exp Physiol 76, 615–618.
261 M Takasaki , H Inaba , A Ohta , (2000) Dietary short-chain fructooligosaccharides increase calbindin-D9k levels only in the large intestine in rats independent of dietary calcium deficiency or serum 1,25 dihydroxy vitamin D levels. Int J Vitam Nutr Res 70, 206–213.
262 L Raschka & H Daniel (2005) Mechanisms underlying the effects of inulin-type fructans on calcium absorption in the large intestine of rats. Bone 37, 728–735.
263 KE Scholz-Ahrens & J Schrezenmeir (2002) Inulin, oligofructose and mineral metabolism – experimental data and mechanism. Br J Nutr 87, Suppl. 2, S179–S186.
265 AC Beynen , JC Baas , PE Hoekemeijer , (2002) Faecal bacterial profile, nitrogen excretion and mineral absorption in healthy dogs fed supplemental oligofructose. J Anim Physiol Anim Nutr (Berl) 86, 298–305.
267 S Leonhard-Marek , G Gabel & H Martens (1998) Effects of short chain fatty acids and carbon dioxide on magnesium transport across sheep rumen epithelium. Exp Physiol 83, 155–164.
268 N Delzenne , J Aertssens , H Verplaetse , (1995) Effect of fermentable fructo-oligosaccharides on mineral, nitrogen and energy digestive balance in the rat. Life Sci 57, 1579–1587.
269 KW Yap , S Mohamed , AM Yazid , (2005) Dose-response effects of inulin on the faecal fatty acids content and mineral absorption of formula-fed infants. Nutr Food Sci 35, 208–219.
272 IJ Griffin , PD Hicks , RP Heaney , (2003) Enriched chicory inulin increases calcium absorption mainly in girls with lower calcium absorption. Nutr Res 23, 901–909.
273 EG van den Heuvel , T Muijs , F Brouns , (2009) Short-chain fructo-oligosaccharides improve magnesium absorption in adolescent girls with a low calcium intake. Nutr Res 29, 229–237.
275 KDA Cashman (2006) A prebiotic substance persistently enhances intestinal calcium absorption and increases bone mineralization in young adolescents. Nutr Rev 64, 189–196.
277 C Coudray , J Bellanger , C Castiglia-Delavaud , (1997) Effect of soluble or partly soluble dietary fibres supplementation on absorption and balance of calcium, magnesium, iron and zinc in healthy young men. Eur J Clin Nutr 51, 375–380.
279 U Teuri , M Karkkainen , C Lamberg-Allardt , (1999) Addition of inulin to breakfast does not acutely affect serum ionized calcium and parathyroid hormone concentrations. Ann Nutr Metab 43, 356–364.
282 V Ducros , J Arnaud , M Tahiri , (2005) Influence of short-chain fructo-oligosaccharides (sc-FOS) on absorption of Cu, Zn, and Se in healthy postmenopausal women. J Am Coll Nutr 24, 30–37.
283 M Tahiri , JC Tressol , J Arnaud , (2001) Five-week intake of short-chain fructo-oligosaccharides increases intestinal absorption and status of magnesium in postmenopausal women. J Bone Miner Res 16, 2152–2160.
285 EG van den Heuvel , T Muijs , W van Dokkum , (1999) Lactulose stimulates calcium absorption in postmenopausal women. J Bone Miner Res 14, 1211–1216.
287 B Adolphi , KE Scholz-Ahrens , M de Vrese , (2009) Short-term effect of bedtime consumption of fermented milk supplemented with calcium, inulin-type fructans and caseinphosphopeptides on bone metabolism in healthy, postmenopausal women. Eur J Nutr 48, 45–53.
290 WJ Dahl , SJ Whiting , TM Isaac , (2005) Effects of thickened beverages fortified with inulin on beverage acceptance, gastrointestinal function, and bone resorption in institutionalized adults. Nutrition 21, 308–311.
293 L Ellegard , H Andersson & I Bosaeus (1997) Inulin and oligofructose do not influence the absorption of cholesterol, or the excretion of cholesterol, Ca, Mg, Zn, Fe, or bile acids but increases energy excretion in ileostomy subjects. Eur J Clin Nutr 51, 1–5.
298 C Coudray , JC Tressol , E Gueux , (2003) Effects of inulin-type fructans of different chain length and type of branching on intestinal absorption and balance of calcium and magnesium in rats. Eur J Nutr 42, 91–98.
303 J Mathey , C Puel , S Kati-Coulibaly , (2004) Fructooligosaccharides maximize bone-sparing effects of soy isoflavone-enriched diet in the ovariectomized rat. Calcif Tissue Int 75, 169–179.
304 L Devareddy , DA Khalil , K Korlagunta , (2006) The effects of fructo-oligosaccharides in combination with soy protein on bone in osteopenic ovariectomized rats. Menopause 13, 692–699.
305 TA Zafar , CM Weaver , K Jones , (2004) Inulin effects on bioavailability of soy isoflavones and their calcium absorption enhancing ability. J Agric Food Chem 52, 2827–2831.
307 A Ohta , S Baba , T Takizawa , (1994) Effects of fructooligosaccharides on the absorption of magnesium in the magnesium-deficient rat model. J Nutr Sci Vitaminol (Tokyo) 40, 171–180.
308 A Ohta , M Ohtsuki , S Baba , (1995) Effects of fructooligosaccharides on the absorption of iron, calcium and magnesium in iron-deficient anemic rats. J Nutr Sci Vitaminol (Tokyo) 41, 281–291.
310 PD Cani & NM Delzenne (2009) The role of the gut microbiota in energy metabolism and metabolic disease. Curr Pharm Des 15, 1546–1558.
312 PD Cani , S Possemiers , WT van de , (2009) Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 58, 1091–1103.
313 OB Chaudhri , V Salem , KG Murphy , (2008) Gastrointestinal satiety signals. Annu Rev Physiol 70, 239–255.
314 MR Druce , CJ Small & SR Bloom (2004) Minireview: gut peptides regulating satiety. Endocrinology 145, 2660–2665.
315 K Wynne , S Stanley , B McGowan , (2005) Appetite control. J Endocrinol 184, 291–318.
316 C Knauf , PD Cani , C Perrin , (2005) Brain glucagon-like peptide-1 increases insulin secretion and muscle insulin resistance to favor hepatic glycogen storage. J Clin Invest 115, 3554–3563.
320 PD Cani , C Knauf , MA Iglesias , (2006) Improvement of glucose tolerance and hepatic insulin sensitivity by oligofructose requires a functional glucagon-like peptide 1 receptor. Diabetes 55, 1484–1490.
321 RA Reimer & JC Russell (2008) Glucose tolerance, lipids, and GLP-1 secretion in JCR:LA-cp rats fed a high protein fiber diet. Obesity (Silver Spring) 16, 40–46.
322 AD Maurer , Q Chen , C McPherson , (2009) Changes in satiety hormones and expression of genes involved in glucose and lipid metabolism in rats weaned onto diets high in fibre or protein reflect susceptibility to increased fat mass in adulthood. J Physiol 587, 679–691.
324 PD Cani , E Joly , Y Horsmans , (2006) Oligofructose promotes satiety in healthy human: a pilot study. Eur J Clin Nutr 60, 567–572.
326 T Piche , SB des Varannes , S Sacher-Huvelin , (2003) Colonic fermentation influences lower esophageal sphincter function in gastroesophageal reflux disease. Gastroenterology 124, 894–902.
327 PD Cani , E Lecourt , EM Dewulf , (2009) Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal. Am J Clin Nutr 90, 1236–1243.
328 SA Abrams , IJ Griffin , KM Hawthorne , (2007) Effect of prebiotic supplementation and calcium intake on body mass index. J Pediatr 151, 293–298.
329 S Genta , W Cabrera , N Habib , (2009) Yacon syrup: beneficial effects on obesity and insulin resistance in humans. Clin Nutr 28, 182–187.
330 JA Parnell & RA Reimer (2009) Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults. Am J Clin Nutr 89, 1751–1759.
331 HP Peters , HM Boers , E Haddeman , (2009) No effect of added beta-glucan or of fructooligosaccharide on appetite or energy intake. Am J Clin Nutr 89, 58–63.
333 NN Kok , HS Taper & NM Delzenne (1998) Oligofructose modulates lipid metabolism alterations induced by a fat-rich diet in rats. J Appl Toxicol 18, 47–53.
334 PD Cani , AM Neyrinck , N Maton , (2005) Oligofructose promotes satiety in rats fed a high-fat diet: involvement of glucagon-like peptide-1. Obes Res 13, 1000–1007.
335 E Delmee , PD Cani , G Gual , (2006) Relation between colonic proglucagon expression and metabolic response to oligofructose in high fat diet-fed mice. Life Sci 79, 1007–1013.
336 PD Cani , CA Daubioul , B Reusens , (2005) Involvement of endogenous glucagon-like peptide-1(7-36) amide on glycaemia-lowering effect of oligofructose in streptozotocin-treated rats. J Endocrinol 185, 457–465.
341 R Giacco , G Clemente , D Luongo , (2004) Effects of short-chain fructo-oligosaccharides on glucose and lipid metabolism in mild hypercholesterolaemic individuals. Clin Nutr 23, 331–340.
342 NM Delzenne & PD Cani (2008) Gut microflora is a key player in host energy homeostasis. Med Sci (Paris) 24, 505–510.
343 NM Delzenne & CM Williams (2002) Prebiotics and lipid metabolism. Curr Opin Lipidol 13, 61–67.
346 NM Delzenne , C Daubioul , A Neyrinck , (2002) Inulin and oligofructose modulate lipid metabolism in animals: review of biochemical events and future prospects. Br J Nutr 87, S255–S259.
347 S Sakakibara , T Yamauchi , Y Oshima , (2006) Acetic acid activates hepatic AMPK and reduces hyperglycemia in diabetic KK-A(y) mice. Biochem Biophys Res Commun 344, 597–604.
349 M Fiordaliso , N Kok , JP Desager , (1995) Dietary oligofructose lowers triglycerides, phospholipids and cholesterol in serum and very low density lipoproteins of rats. Lipids 30, 163–167.
352 EA Trautwein , K Forgbert , D Rieckhoff , (1999) Impact of beta-cyclodextrin and resistant starch on bile acid metabolism and fecal steroid excretion in regard to their hypolipidemic action in hamsters. Biochim Biophys Acta Mol Cell Biol Lipids 1437, 1–12.
354 H van Meer , G Boehm , F Stellaard , (2008) Prebiotic oligosaccharides and the enterohepatic circulation of bile salts in rats. Am J Physiol Gastrointest Liver Physiol 294, G540–G547.
356 F Diraison , P Moulin & M Beylot (2003) Contribution of hepatic de novo lipogenesis and reesterification of plasma non esterified fatty acids to plasma triglyceride synthesis during non-alcoholic fatty liver disease. Diabet Metab 29, 478–485.
357 CA Daubioul , Y Horsmans , P Lambert , (2005) Effects of oligofructose on glucose and lipid metabolism in patients with nonalcoholic steatohepatitis: results of a pilot study. Eur J Clin Nutr 59, 723–726.
358 PD Cani & NM Delzenne (2009) Interplay between obesity and associated metabolic disorders: new insights into the gut microbiota. Curr Opin Pharmacol 9, 737–743.
359 PD Cani , J Amar , MA Iglesias , (2007) Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56, 1761–1772.
360 PJ Turnbaugh , F Backhed , L Fulton , (2008) Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe 3, 213–223.
361 PD Cani , AM Neyrinck , F Fava , (2007) Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 50, 2374–2383.
362 PD Cani , R Bibiloni , C Knauf , (2008) Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57, 1470–1481.
363 A Waldram , E Holmes , Y Wang , (2009) Top-down systems biology modeling of host metabotype-microbiome associations in obese rodents. J Proteome Res 8, 2361–2375.
364 Z Wang , G Xiao , Y Yao , (2006) The role of bifidobacteria in gut barrier function after thermal injury in rats. J Trauma 61, 650–657.
365 EA Griffiths , LC Duffy , FL Schanbacher , (2004) In vivo effects of bifidobacteria and lactoferrin on gut endotoxin concentration and mucosal immunity in Balb/c mice. Dig Dis Sci 49, 579–589.
366 ZT Wang , YM Yao , GX Xiao , (2004) Risk factors of development of gut-derived bacterial translocation in thermally injured rats. World J Gastroenterol 10, 1619–1624.
367 X Ruan , H Shi , G Xia , (2007) Encapsulated bifidobacteria reduced bacterial translocation in rats following hemorrhagic shock and resuscitation. Nutrition 23, 754–761.
368 MJ Keenan , J Zhou , KL McCutcheon , (2006) Effects of resistant starch, a non-digestible fermentable fiber, on reducing body fat. Obesity (Silver Spring) 14, 1523–1534.
369 J Zhou , RJ Martin , RT Tulley , (2008) Dietary resistant starch upregulates total GLP-1 and PYY in a sustained day-long manner through fermentation in rodents. Am J Physiol Endocrinol Metab 295, E1160–E1166.
371 TC Adam & MS Westerterp-Plantenga (2005) Nutrient-stimulated GLP-1 release in normal-weight men and women. Horm Metab Res 37, 111–117.
373 Z Gao , J Yin , J Zhang , (2009) Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes 58, 1509–1517.
375 AC Lundell , I Adlerberth , E Lindberg , (2007) Increased levels of circulating soluble CD14 but not CD83 in infants are associated with early intestinal colonization with Staphylococcus aureus. Clin Exp Allergy 37, 62–71.
376 MM Gronlund , M Gueimonde , K Laitinen , (2007) Maternal breast-milk and intestinal bifidobacteria guide the compositional development of the Bifidobacterium microbiota in infants at risk of allergic disease. Clin Exp Allergy 37, 1764–1772.
378 S Salminen , GR Gibson , AL McCartney , (2004) Influence of mode of delivery on gut microbiota composition in seven year old children. Gut 53, 1388–1389.
379 S Salminen & E Isolauri (2008) Opportunities for improving the health and nutrition of the human infant by probiotics. Nestle Nutr Workshop Ser Pediatr Program 62, 223–233.
380 S Salminen , MC Collado , E Isolauri , (2009) Microbial-host interactions: selecting the right probiotics and prebiotics for infants. Nestle Nutr Workshop Ser Pediatr Program 64, 201–213.
382 J Walter , GW Tannock , A Tilsala-Timisjarvi , (2000) Detection and identification of gastrointestinal Lactobacillus species by using denaturing gradient gel electrophoresis and species-specific PCR primers. Appl Environ Microbiol 66, 297–303.
383 RM Satokari , EE Vaughan , AD Akkermans , (2001) Bifidobacterial diversity in human feces detected by genus-specific PCR and denaturing gradient gel electrophoresis. Appl Environ Microbiol 67, 504–513.
384 HG Heilig , EG Zoetendal , EE Vaughan , (2002) Molecular diversity of Lactobacillus spp. and other lactic acid bacteria in the human intestine as determined by specific amplification of 16S ribosomal DNA. Appl Environ Microbiol 68, 114–123.
385 J Shen , B Zhang , G Wei , (2006) Molecular profiling of the Clostridium leptum subgroup in human fecal microflora by PCR-denaturing gradient gel electrophoresis and clone library analysis. Appl Environ Microbiol 72, 5232–5238.
386 T Vanhoutte , V de Preter , E De Brandt , (2006) Molecular monitoring of the fecal microbiota of healthy human subjects during administration of lactulose and Saccharomyces boulardii. Appl Environ Microbiol 72, 5990–5997.
389 GR Gibson , ER Beatty , X Wang , (1995) Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin. Gastroenterology 108, 975–982.
394 U Teuri , R Korpela , M Saxelin , (1998) Increased fecal frequency and gastrointestinal symptoms following ingestion of galacto-oligosaccharide-containing yogurt. J Nutr Sci Vitaminol (Tokyo) 44, 465–471.
395 G Moro , I Minoli , M Mosca , (2002) Dosage-related bifidogenic effects of galacto- and fructooligosaccharides in formula-fed term infants. J Pediatr Gastroenterol Nutr 34, 291–295.
397 Y Bouhnik , L Achour , D Paineau , (2007) Four-week short chain fructo-oligosaccharides ingestion leads to increasing fecal bifidobacteria and cholesterol excretion in healthy elderly volunteers. Nutrition 6, 42–46.
399 KM Tuohy , RK Finlay , AG Wynne , (2001) A human volunteer study on the prebiotic effects of HP-inulin – Faecal bacteria enumerated using fluorescent in situ hybridisation (FISH). Anaerobe 7, 113–118.
400 CH Williams , SA Witherly & RK Buddington (1994) Influence of dietary neosugar on selected bacterial groups of the human fecal microbiota. Microbial Ecol Health Dis 7, 91–97.
403 J Mattö , L Maunuksela , K Kajander , (2005) Composition and temporal stability of gastrointestinal microbiota in irritable bowel syndrome – a longitudinal study in IBS and control subjects. FEMS Immunol Med Microbiol 43, 213–222.
405 M Roberfroid (1997) Dietary Fiber in Health and Disease. New York: Plenum Press.
408 SJ Fairweather-Tait & IT Johnson (1999) Bioavailability of minerals. In Colonic Microbiota, Nutrition and Health, pp. 233–244 [ GR Gibson and MB Roberfroid , editors]. Dordrecht: Kluwer Academic Publishers.
409 IG Carabin & WG Flamm (1999) Evaluation of safety of inulin and oligofructose as dietary fiber. Regul Toxicol Pharmacol 30, 268–282.
412 M Roberfroid (2002) Functional foods: concepts and application to inulin and oligofructose. Br J Nutr 87, S139–S143.
413 KD Cashman (2002) Calcium intake, calcium bioavailability and bone health. Br J Nutr 87, Suppl. 2, S169–S177.
414 N Kaur & AK Gupta (2002) Applications of inulin and oligofructose in health and nutrition. J Biosci 27, 703–714.
416 A Bongers & EGHM van den Heuvel (2003) Prebiotics and the bioavailability of minerals and trace elements. Food Rev Int 19, 397–422.
422 A Franck (2006) Oligofructose-enriched inulin stimulates calcium absorption and bone mineralisation. Nutr Bull 31, 341–345.
423 D Bosscher , JV Loo & A Franck (2006) Inulin and oligofructose as functional ingredients to improve bone mineralization. Int Dairy J 1092–1097.
427 H Alexiou & A Franck (2008) Prebiotic inulin-type fructans: nutritional benefits beyond dietary fibre source. Beneo-Orafti Nutr Bull 33, 227–233.
428 GR Gibson & NM Delzenne (2008) Inulin and oligofructose. Nutr Today 43, 54–59.
434 O Chonan , K Matsumoto & M Watanuki (1995) Effect of galactooligosaccharides on calcium absorption and preventing bone loss in ovariectomized rats. Biosci Biotechnol Biochem 59, 236–239.
439 R Mitamura & H Hara (2006) Ingestion of difructose anhydride III partially restores calcium absorption impaired by vitamin D and estrogen deficiency in rats. Eur J Nutr 45, 242–249.
440 A Nzeusseu , D Dienst , V Haufroid , (2006) Inulin and fructo-oligosaccharides differ in their ability to enhance the density of cancellous and cortical bone in the axial and peripheral skeleton of growing rats. Bone 38, 394–399.
441 AR Lobo , C Colli & TMCC Filisetti (2006) Fructooligosaccharides improve bone mass and biomechanical properties in rats. Nutr Res 26, 413–420.
443 C Demigne , H Jacobs , C Moundras , (2008) Comparison of native or reformulated chicory fructans, or non-purified chicory, on rat cecal fermentation and mineral metabolism. Eur J Nutr 47, 366–374.
444 AR Lobo , JM Filho , EP Alvares , (2009) Effects of dietary lipid composition and inulin-type fructans on mineral bioavailability in growing rats. Nutrition 25, 216–225.
446 O Chonan & M Watanuki (1995) Effect of galactooligosaccharides on calcium absorption in rats. J Nutr Sci Vitaminol (Tokyo) 41, 95–104.
447 S Yanahira , M Morita , S Aoe , (1997) Effects of lactitol-oligosaccharides on calcium and magnesium absorption in rats. J Nutr Sci Vitaminol (Tokyo) 43, 123–132.
451 P Asvarujanon , S Ishizuka & H Hara (2005) Promotive effects of non-digestible disaccharides on rat mineral absorption depend on the type of saccharide. Nutrition 21, 1025–1035.
452 C Coudray , C Feillet-Coudray , JC Tressol , (2005) Stimulatory effect of inulin on intestinal absorption of calcium and magnesium in rats is modulated by dietary calcium intakes short- and long-term balance studies. Eur J Nutr 44, 293–302.
453 C Coudray , M Rambeau , C Feillet-Coudray , (2005) Dietary inulin intake and age can significantly affect intestinal absorption of calcium and magnesium in rats: a stable isotope approach. Nutr J 4, 29.
454 K Shiga , M Nishimukai , F Tomita , (2006) Ingestion of difructose anhydride III, a non-digestible disaccharide, prevents gastrectomy-induced iron malabsorption and anemia in rats. Nutrition 22, 786–793.
456 M Azorin-Ortuno , C Urban , JJ Ceron , (2009) Effect of low inulin doses with different polymerisation degree on lipid metabolism, mineral absorption, and intestinal microbiota in rats with fat-supplemented diet. Food Chem 113, 1058–1065.
458 Y Wang , T Zeng , SE Wang , (2010) Fructo-oligosaccharides enhance the mineral absorption and counteract the adverse effects of phytic acid in mice. Nutrition 26, 305–311.
461 J Juskiewicz , J Jankowski , Z Zdunczyk , (2006) Performance and gastrointestinal tract metabolism of turkeys fed diets with different contents of fructooligosaccharides. Poult Sci 85, 886.
462 Z Zdunczyk , J Juskiewicz & I Estrella (2006) Cecal parameters of rats fed diets containing grapefruit polyphenols and inulin as single supplements or in a combination. Nutrition 22, 898.
463 J Sugatani , T Wada , M Osabe , (2006) Dietary inulin alleviates hepatic steatosis and xenobiotics-induced liver injury in rats fed a high-fat and high-sucrose diet: association with the suppression of hepatic cytochrome P450 and hepatocyte nuclear factor 4alpha expression. Drug Metab Dispos 34, 1677–1687.